APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Market Analysis & Forecast

Global Radiopharmaceutical Market Analysis and Forecast 2026-2032

25 December 2025199 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global Radiopharmaceutical top three manufacturers include the Bracco Imaging, Bayer and Mallinckrodt, with about 47% market shares. North America and Europe is the main consumption places, with a consumption market share nearly 45% and 27%.

This report presents an overview of global market for Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Radiopharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.

Radiopharmaceutical Segment by Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceutical Segment by Type

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Radiopharmaceutical Segment by Application

Oncology

Cardiology

Other

Radiopharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Radiopharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiopharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Actinium-225 Major Manufacturers Table 3. Lutetium-177 Major Manufacturers Table 4. Radium-223 Major Manufacturers Table 5. Holmium-166 Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Radiopharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Oncology Major Manufacturers Table 9. Cardiology Major Manufacturers Table 10. Other Major Manufacturers Table 11. Radiopharmaceutical Industry Trends Table 12. Radiopharmaceutical Industry Drivers Table 13. Radiopharmaceutical Industry Opportunities and Challenges Table 14. Radiopharmaceutical Industry Restraints Table 15. Global Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Radiopharmaceutical Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Radiopharmaceutical Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Radiopharmaceutical Revenue Market Share by Region (2021-2026) Table 19. Global Radiopharmaceutical Revenue Market Share by Region (2027-2032) Table 20. Global Radiopharmaceutical Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 21. Global Radiopharmaceutical Sales by Region (2021-2026) & (M Doses) Table 22. Global Radiopharmaceutical Sales by Region (2027-2032) & (M Doses) Table 23. Global Radiopharmaceutical Sales Market Share by Region (2021-2026) Table 24. Global Radiopharmaceutical Sales Market Share by Region (2027-2032) Table 25. Global Radiopharmaceutical Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Radiopharmaceutical Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Radiopharmaceutical Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Radiopharmaceutical Sales Market Share by Manufacturers (2021-2026) Table 29. Global Radiopharmaceutical Sales Price (USD/Dose) of Manufacturers (2021-2026) Table 30. Global Radiopharmaceutical Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Radiopharmaceutical Manufacturers, Product Type & Application Table 33. Global Radiopharmaceutical Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Radiopharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Radiopharmaceutical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Radiopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Radiopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Radiopharmaceutical Revenue Market Share by Type (2021-2026) Table 40. Global Radiopharmaceutical Revenue Market Share by Type (2027-2032) Table 41. Global Radiopharmaceutical Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 42. Global Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 43. Global Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 44. Global Radiopharmaceutical Sales Market Share by Type (2021-2026) Table 45. Global Radiopharmaceutical Sales Market Share by Type (2027-2032) Table 46. Global Radiopharmaceutical Price by Type (2021-2026) & (USD/Dose) Table 47. Global Radiopharmaceutical Price by Type (2027-2032) & (USD/Dose) Table 48. Global Radiopharmaceutical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Radiopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Radiopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Radiopharmaceutical Revenue Market Share by Application (2021-2026) Table 52. Global Radiopharmaceutical Revenue Market Share by Application (2027-2032) Table 53. Global Radiopharmaceutical Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 54. Global Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 55. Global Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 56. Global Radiopharmaceutical Sales Market Share by Application (2021-2026) Table 57. Global Radiopharmaceutical Sales Market Share by Application (2027-2032) Table 58. Global Radiopharmaceutical Price by Application (2021-2026) & (USD/Dose) Table 59. Global Radiopharmaceutical Price by Application (2027-2032) & (USD/Dose) Table 60. Bracco Imaging Company Information Table 61. Bracco Imaging Business Overview Table 62. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 63. Bracco Imaging Radiopharmaceutical Product Portfolio Table 64. Bracco Imaging Recent Development Table 65. Bayer Company Information Table 66. Bayer Business Overview Table 67. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 68. Bayer Radiopharmaceutical Product Portfolio Table 69. Bayer Recent Development Table 70. Mallinckrodt Company Information Table 71. Mallinckrodt Business Overview Table 72. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 73. Mallinckrodt Radiopharmaceutical Product Portfolio Table 74. Mallinckrodt Recent Development Table 75. Nordion Company Information Table 76. Nordion Business Overview Table 77. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 78. Nordion Radiopharmaceutical Product Portfolio Table 79. Nordion Recent Development Table 80. Triad Isotopes Company Information Table 81. Triad Isotopes Business Overview Table 82. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 83. Triad Isotopes Radiopharmaceutical Product Portfolio Table 84. Triad Isotopes Recent Development Table 85. Lantheus Company Information Table 86. Lantheus Business Overview Table 87. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 88. Lantheus Radiopharmaceutical Product Portfolio Table 89. Lantheus Recent Development Table 90. IBA Group Company Information Table 91. IBA Group Business Overview Table 92. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 93. IBA Group Radiopharmaceutical Product Portfolio Table 94. IBA Group Recent Development Table 95. GE Healthcare Company Information Table 96. GE Healthcare Business Overview Table 97. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 98. GE Healthcare Radiopharmaceutical Product Portfolio Table 99. GE Healthcare Recent Development Table 100. China Isotope & Radiation Company Information Table 101. China Isotope & Radiation Business Overview Table 102. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 103. China Isotope & Radiation Radiopharmaceutical Product Portfolio Table 104. China Isotope & Radiation Recent Development Table 105. Jubilant Pharma Company Information Table 106. Jubilant Pharma Business Overview Table 107. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 108. Jubilant Pharma Radiopharmaceutical Product Portfolio Table 109. Jubilant Pharma Recent Development Table 110. Eli Lilly Company Information Table 111. Eli Lilly Business Overview Table 112. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 113. Eli Lilly Radiopharmaceutical Product Portfolio Table 114. Eli Lilly Recent Development Table 115. Advanced Accelerator Applications Company Information Table 116. Advanced Accelerator Applications Business Overview Table 117. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 118. Advanced Accelerator Applications Radiopharmaceutical Product Portfolio Table 119. Advanced Accelerator Applications Recent Development Table 120. SIEMENS Company Information Table 121. SIEMENS Business Overview Table 122. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 123. SIEMENS Radiopharmaceutical Product Portfolio Table 124. SIEMENS Recent Development Table 125. Dongcheng Company Information Table 126. Dongcheng Business Overview Table 127. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 128. Dongcheng Radiopharmaceutical Product Portfolio Table 129. Dongcheng Recent Development Table 130. Navidea Company Information Table 131. Navidea Business Overview Table 132. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2021-2026) Table 133. Navidea Radiopharmaceutical Product Portfolio Table 134. Navidea Recent Development Table 135. North America Radiopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Radiopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 138. North America Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 139. North America Radiopharmaceutical Sales Price by Type (2021-2026) & (USD/Dose) Table 140. North America Radiopharmaceutical Sales Price by Type (2027-2032) & (USD/Dose) Table 141. North America Radiopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Radiopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 144. North America Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 145. North America Radiopharmaceutical Sales Price by Application (2021-2026) & (USD/Dose) Table 146. North America Radiopharmaceutical Sales Price by Application (2027-2032) & (USD/Dose) Table 147. North America Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Radiopharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Radiopharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 151. North America Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 152. North America Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 153. North America Radiopharmaceutical Sales Price by Country (2021-2026) & (USD/Dose) Table 154. North America Radiopharmaceutical Sales Price by Country (2027-2032) & (USD/Dose) Table 155. United States Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 156. Canada Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 157. Mexico Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 158. Europe Radiopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Radiopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 161. Europe Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 162. Europe Radiopharmaceutical Sales Price by Type (2021-2026) & (USD/Dose) Table 163. Europe Radiopharmaceutical Sales Price by Type (2027-2032) & (USD/Dose) Table 164. Europe Radiopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Radiopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 167. Europe Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 168. Europe Radiopharmaceutical Sales Price by Application (2021-2026) & (USD/Dose) Table 169. Europe Radiopharmaceutical Sales Price by Application (2027-2032) & (USD/Dose) Table 170. Europe Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Radiopharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Radiopharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 174. Europe Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 175. Europe Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 176. Europe Radiopharmaceutical Sales Price by Country (2021-2026) & (USD/Dose) Table 177. Europe Radiopharmaceutical Sales Price by Country (2027-2032) & (USD/Dose) Table 178. Germany Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 179. France Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 180. U.K. Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 181. Italy Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 182. Russia Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 183. Spain Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 185. Switzerland Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 186. Sweden Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 187. Poland Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 188. China Radiopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 189. China Radiopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 190. China Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 191. China Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 192. China Radiopharmaceutical Sales Price by Type (2021-2026) & (USD/Dose) Table 193. China Radiopharmaceutical Sales Price by Type (2027-2032) & (USD/Dose) Table 194. China Radiopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 195. China Radiopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 196. China Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 197. China Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 198. China Radiopharmaceutical Sales Price by Application (2021-2026) & (USD/Dose) Table 199. China Radiopharmaceutical Sales Price by Application (2027-2032) & (USD/Dose) Table 200. Asia Radiopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 201. Asia Radiopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 202. Asia Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 203. Asia Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 204. Asia Radiopharmaceutical Sales Price by Type (2021-2026) & (USD/Dose) Table 205. Asia Radiopharmaceutical Sales Price by Type (2027-2032) & (USD/Dose) Table 206. Asia Radiopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 207. Asia Radiopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 209. Asia Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 210. Asia Radiopharmaceutical Sales Price by Application (2021-2026) & (USD/Dose) Table 211. Asia Radiopharmaceutical Sales Price by Application (2027-2032) & (USD/Dose) Table 212. Asia Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Radiopharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Asia Radiopharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Asia Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 216. Asia Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 217. Asia Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 218. Asia Radiopharmaceutical Sales Price by Country (2021-2026) & (USD/Dose) Table 219. Asia Radiopharmaceutical Sales Price by Country (2027-2032) & (USD/Dose) Table 220. Japan Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 221. South Korea Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 222. India Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 223. Australia Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 224. Taiwan Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 225. Southeast Asia Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 226. SAMEA Radiopharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 227. SAMEA Radiopharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 228. SAMEA Radiopharmaceutical Sales by Type (2021-2026) & (M Doses) Table 229. SAMEA Radiopharmaceutical Sales by Type (2027-2032) & (M Doses) Table 230. SAMEA Radiopharmaceutical Sales Price by Type (2021-2026) & (USD/Dose) Table 231. SAMEA Radiopharmaceutical Sales Price by Type (2027-2032) & (USD/Dose) Table 232. SAMEA Radiopharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 233. SAMEA Radiopharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 234. SAMEA Radiopharmaceutical Sales by Application (2021-2026) & (M Doses) Table 235. SAMEA Radiopharmaceutical Sales by Application (2027-2032) & (M Doses) Table 236. SAMEA Radiopharmaceutical Sales Price by Application (2021-2026) & (USD/Dose) Table 237. SAMEA Radiopharmaceutical Sales Price by Application (2027-2032) & (USD/Dose) Table 238. SAMEA Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. SAMEA Radiopharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. SAMEA Radiopharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. SAMEA Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 242. SAMEA Radiopharmaceutical Sales by Country (2021-2026) & (M Doses) Table 243. SAMEA Radiopharmaceutical Sales by Country (2027-2032) & (M Doses) Table 244. SAMEA Radiopharmaceutical Sales Price by Country (2021-2026) & (USD/Dose) Table 245. SAMEA Radiopharmaceutical Sales Price by Country (2027-2032) & (USD/Dose) Table 246. Brazil Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 247. Argentina Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 248. Chile Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 249. Colombia Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 250. Peru Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 251. Saudi Arabia Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 252. Israel Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 253. UAE Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 254. Turkey Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 255. Iran Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 256. Egypt Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Radiopharmaceutical Distributors List Table 260. Radiopharmaceutical Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Radiopharmaceutical Image Figure 2. Global Radiopharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Actinium-225 Image Figure 5. Lutetium-177 Image Figure 6. Radium-223 Image Figure 7. Holmium-166 Image Figure 8. Other Image Figure 9. Global Radiopharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Radiopharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 11. Oncology Image Figure 12. Cardiology Image Figure 13. Other Image Figure 14. Global Radiopharmaceutical Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Radiopharmaceutical Revenue (2021-2032) & (US$ Million) Figure 16. Global Radiopharmaceutical Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Radiopharmaceutical Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Radiopharmaceutical Revenue Market Share by Region (2021-2032) Figure 19. Global Radiopharmaceutical Sales (2021-2032) & (M Doses) Figure 20. Global Radiopharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 21. Global Radiopharmaceutical Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Radiopharmaceutical Sales YoY (2021-2032) & (M Doses) Figure 23. Europe Radiopharmaceutical Sales YoY (2021-2032) & (M Doses) Figure 24. China Radiopharmaceutical Sales YoY (2021-2032) & (M Doses) Figure 25. Asia (Excluding China) Radiopharmaceutical Sales YoY (2021-2032) & (M Doses) Figure 26. South America, Middle East and Africa Radiopharmaceutical Sales YoY (2021-2032) & (M Doses) Figure 27. Global Radiopharmaceutical Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Radiopharmaceutical Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Radiopharmaceutical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Radiopharmaceutical Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Radiopharmaceutical Revenue Market Share by Type (2021-2032) Figure 33. Global Radiopharmaceutical Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 34. Global Radiopharmaceutical Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Radiopharmaceutical Sales Market Share by Type (2021-2032) Figure 36. Global Radiopharmaceutical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Radiopharmaceutical Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Radiopharmaceutical Revenue Market Share by Application (2021-2032) Figure 39. Global Radiopharmaceutical Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 40. Global Radiopharmaceutical Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Radiopharmaceutical Sales Market Share by Application (2021-2032) Figure 42. North America Radiopharmaceutical Revenue Share by Type (2021-2032) Figure 43. North America Radiopharmaceutical Sales Share by Type (2021-2032) Figure 44. North America Radiopharmaceutical Revenue Share by Application (2021-2032) Figure 45. North America Radiopharmaceutical Sales Share by Application (2021-2032) Figure 46. North America Radiopharmaceutical Revenue Share by Country (2021-2032) Figure 47. North America Radiopharmaceutical Sales Share by Country (2021-2032) Figure 48. Europe Radiopharmaceutical Revenue Share by Type (2021-2032) Figure 49. Europe Radiopharmaceutical Sales Share by Type (2021-2032) Figure 50. Europe Radiopharmaceutical Revenue Share by Application (2021-2032) Figure 51. Europe Radiopharmaceutical Sales Share by Application (2021-2032) Figure 52. Europe Radiopharmaceutical Revenue Share by Country (2021-2032) Figure 53. Europe Radiopharmaceutical Sales Share by Country (2021-2032) Figure 54. China Radiopharmaceutical Revenue Share by Type (2021-2032) Figure 55. China Radiopharmaceutical Sales Share by Type (2021-2032) Figure 56. China Radiopharmaceutical Revenue Share by Application (2021-2032) Figure 57. China Radiopharmaceutical Sales Share by Application (2021-2032) Figure 58. Asia Radiopharmaceutical Revenue Share by Type (2021-2032) Figure 59. Asia Radiopharmaceutical Sales Share by Type (2021-2032) Figure 60. Asia Radiopharmaceutical Revenue Share by Application (2021-2032) Figure 61. Asia Radiopharmaceutical Sales Share by Application (2021-2032) Figure 62. Asia Radiopharmaceutical Revenue Share by Country (2021-2032) Figure 63. Asia Radiopharmaceutical Sales Share by Country (2021-2032) Figure 64. SAMEA Radiopharmaceutical Revenue Share by Type (2021-2032) Figure 65. SAMEA Radiopharmaceutical Sales Share by Type (2021-2032) Figure 66. SAMEA Radiopharmaceutical Revenue Share by Application (2021-2032) Figure 67. SAMEA Radiopharmaceutical Sales Share by Application (2021-2032) Figure 68. SAMEA Radiopharmaceutical Revenue Share by Country (2021-2032) Figure 69. SAMEA Radiopharmaceutical Sales Share by Country (2021-2032) Figure 70. Radiopharmaceutical Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Radiopharmaceutical Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Actinium-225
  • Lutetium-177
  • Radium-223
  • Holmium-166
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiopharmaceutical Market by Type
  3. 1.2.1 Global Radiopharmaceutical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Actinium-225
  5. 1.2.3 Lutetium-177
  6. 1.2.4 Radium-223
  7. 1.2.5 Holmium-166
  8. 1.2.6 Other
  9. 1.3 Radiopharmaceutical Market by Application
  10. 1.3.1 Global Radiopharmaceutical Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Oncology
  12. 1.3.3 Cardiology
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Radiopharmaceutical Market Dynamics
  1. 2.1 Radiopharmaceutical Industry Trends
  2. 2.2 Radiopharmaceutical Industry Drivers
  3. 2.3 Radiopharmaceutical Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Radiopharmaceutical Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Radiopharmaceutical Revenue by Region
  3. 3.2.1 Global Radiopharmaceutical Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiopharmaceutical Revenue by Region (2021-2026)
  5. 3.2.3 Global Radiopharmaceutical Revenue by Region (2027-2032)
  6. 3.2.4 Global Radiopharmaceutical Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Radiopharmaceutical Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Radiopharmaceutical Sales by Region
  9. 3.4.1 Global Radiopharmaceutical Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Radiopharmaceutical Sales by Region (2021-2026)
  11. 3.4.3 Global Radiopharmaceutical Sales by Region (2027-2032)
  12. 3.4.4 Global Radiopharmaceutical Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Radiopharmaceutical Revenue by Manufacturers
  2. 4.1.1 Global Radiopharmaceutical Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Radiopharmaceutical Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiopharmaceutical Sales by Manufacturers
  6. 4.2.1 Global Radiopharmaceutical Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Radiopharmaceutical Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Radiopharmaceutical Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Radiopharmaceutical Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Radiopharmaceutical Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Radiopharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Radiopharmaceutical Manufacturers, Product Type & Application
  13. 4.7 Global Radiopharmaceutical Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Radiopharmaceutical Market CR5 and HHI
  16. 4.8.2 2025 Radiopharmaceutical Tier 1, Tier 2, and Tier 3
5 Radiopharmaceutical Market by Type
  1. 5.1 Global Radiopharmaceutical Revenue by Type
  2. 5.1.1 Global Radiopharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Radiopharmaceutical Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Radiopharmaceutical Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Radiopharmaceutical Sales by Type
  6. 5.2.1 Global Radiopharmaceutical Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceutical Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Radiopharmaceutical Sales Market Share by Type (2021-2032)
  9. 5.3 Global Radiopharmaceutical Price by Type
6 Radiopharmaceutical Market by Application
  1. 6.1 Global Radiopharmaceutical Revenue by Application
  2. 6.1.1 Global Radiopharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Radiopharmaceutical Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Radiopharmaceutical Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Radiopharmaceutical Sales by Application
  6. 6.2.1 Global Radiopharmaceutical Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Radiopharmaceutical Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Radiopharmaceutical Sales Market Share by Application (2021-2032)
  9. 6.3 Global Radiopharmaceutical Price by Application
7 Company Profiles
  1. 7.1 Bracco Imaging
  2. 7.1.1 Bracco Imaging Company Information
  3. 7.1.2 Bracco Imaging Business Overview
  4. 7.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
  6. 7.1.5 Bracco Imaging Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Radiopharmaceutical Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Mallinckrodt
  14. 7.3.1 Mallinckrodt Company Information
  15. 7.3.2 Mallinckrodt Business Overview
  16. 7.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
  18. 7.3.5 Mallinckrodt Recent Developments
  19. 7.4 Nordion
  20. 7.4.1 Nordion Company Information
  21. 7.4.2 Nordion Business Overview
  22. 7.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nordion Radiopharmaceutical Product Portfolio
  24. 7.4.5 Nordion Recent Developments
  25. 7.5 Triad Isotopes
  26. 7.5.1 Triad Isotopes Company Information
  27. 7.5.2 Triad Isotopes Business Overview
  28. 7.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
  30. 7.5.5 Triad Isotopes Recent Developments
  31. 7.6 Lantheus
  32. 7.6.1 Lantheus Company Information
  33. 7.6.2 Lantheus Business Overview
  34. 7.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lantheus Radiopharmaceutical Product Portfolio
  36. 7.6.5 Lantheus Recent Developments
  37. 7.7 IBA Group
  38. 7.7.1 IBA Group Company Information
  39. 7.7.2 IBA Group Business Overview
  40. 7.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 IBA Group Radiopharmaceutical Product Portfolio
  42. 7.7.5 IBA Group Recent Developments
  43. 7.8 GE Healthcare
  44. 7.8.1 GE Healthcare Company Information
  45. 7.8.2 GE Healthcare Business Overview
  46. 7.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
  48. 7.8.5 GE Healthcare Recent Developments
  49. 7.9 China Isotope & Radiation
  50. 7.9.1 China Isotope & Radiation Company Information
  51. 7.9.2 China Isotope & Radiation Business Overview
  52. 7.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
  54. 7.9.5 China Isotope & Radiation Recent Developments
  55. 7.10 Jubilant Pharma
  56. 7.10.1 Jubilant Pharma Company Information
  57. 7.10.2 Jubilant Pharma Business Overview
  58. 7.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
  60. 7.10.5 Jubilant Pharma Recent Developments
  61. 7.11 Eli Lilly
  62. 7.11.1 Eli Lilly Company Information
  63. 7.11.2 Eli Lilly Business Overview
  64. 7.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
  66. 7.11.5 Eli Lilly Recent Developments
  67. 7.12 Advanced Accelerator Applications
  68. 7.12.1 Advanced Accelerator Applications Company Information
  69. 7.12.2 Advanced Accelerator Applications Business Overview
  70. 7.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
  72. 7.12.5 Advanced Accelerator Applications Recent Developments
  73. 7.13 SIEMENS
  74. 7.13.1 SIEMENS Company Information
  75. 7.13.2 SIEMENS Business Overview
  76. 7.13.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 SIEMENS Radiopharmaceutical Product Portfolio
  78. 7.13.5 SIEMENS Recent Developments
  79. 7.14 Dongcheng
  80. 7.14.1 Dongcheng Company Information
  81. 7.14.2 Dongcheng Business Overview
  82. 7.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Dongcheng Radiopharmaceutical Product Portfolio
  84. 7.14.5 Dongcheng Recent Developments
  85. 7.15 Navidea
  86. 7.15.1 Navidea Company Information
  87. 7.15.2 Navidea Business Overview
  88. 7.15.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Navidea Radiopharmaceutical Product Portfolio
  90. 7.15.5 Navidea Recent Developments
8 North America
  1. 8.1 North America Radiopharmaceutical Market Size by Type
  2. 8.1.1 North America Radiopharmaceutical Revenue by Type (2021-2032)
  3. 8.1.2 North America Radiopharmaceutical Sales by Type (2021-2032)
  4. 8.1.3 North America Radiopharmaceutical Price by Type (2021-2032)
  5. 8.2 North America Radiopharmaceutical Market Size by Application
  6. 8.2.1 North America Radiopharmaceutical Revenue by Application (2021-2032)
  7. 8.2.2 North America Radiopharmaceutical Sales by Application (2021-2032)
  8. 8.2.3 North America Radiopharmaceutical Price by Application (2021-2032)
  9. 8.3 North America Radiopharmaceutical Market Size by Country
  10. 8.3.1 North America Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Radiopharmaceutical Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Radiopharmaceutical Market Size by Type
  2. 9.1.1 Europe Radiopharmaceutical Revenue by Type (2021-2032)
  3. 9.1.2 Europe Radiopharmaceutical Sales by Type (2021-2032)
  4. 9.1.3 Europe Radiopharmaceutical Price by Type (2021-2032)
  5. 9.2 Europe Radiopharmaceutical Market Size by Application
  6. 9.2.1 Europe Radiopharmaceutical Revenue by Application (2021-2032)
  7. 9.2.2 Europe Radiopharmaceutical Sales by Application (2021-2032)
  8. 9.2.3 Europe Radiopharmaceutical Price by Application (2021-2032)
  9. 9.3 Europe Radiopharmaceutical Market Size by Country
  10. 9.3.1 Europe Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Radiopharmaceutical Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Radiopharmaceutical Market Size by Type
  2. 10.1.1 China Radiopharmaceutical Revenue by Type (2021-2032)
  3. 10.1.2 China Radiopharmaceutical Sales by Type (2021-2032)
  4. 10.1.3 China Radiopharmaceutical Price by Type (2021-2032)
  5. 10.2 China Radiopharmaceutical Market Size by Application
  6. 10.2.1 China Radiopharmaceutical Revenue by Application (2021-2032)
  7. 10.2.2 China Radiopharmaceutical Sales by Application (2021-2032)
  8. 10.2.3 China Radiopharmaceutical Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiopharmaceutical Market Size by Type
  2. 11.1.1 Asia Radiopharmaceutical Revenue by Type (2021-2032)
  3. 11.1.2 Asia Radiopharmaceutical Sales by Type (2021-2032)
  4. 11.1.3 Asia Radiopharmaceutical Price by Type (2021-2032)
  5. 11.2 Asia Radiopharmaceutical Market Size by Application
  6. 11.2.1 Asia Radiopharmaceutical Revenue by Application (2021-2032)
  7. 11.2.2 Asia Radiopharmaceutical Sales by Application (2021-2032)
  8. 11.2.3 Asia Radiopharmaceutical Price by Application (2021-2032)
  9. 11.3 Asia Radiopharmaceutical Market Size by Country
  10. 11.3.1 Asia Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Radiopharmaceutical Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiopharmaceutical Market Size by Type
  2. 12.1.1 SAMEA Radiopharmaceutical Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Radiopharmaceutical Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Radiopharmaceutical Price by Type (2021-2032)
  5. 12.2 SAMEA Radiopharmaceutical Market Size by Application
  6. 12.2.1 SAMEA Radiopharmaceutical Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Radiopharmaceutical Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Radiopharmaceutical Price by Application (2021-2032)
  9. 12.3 SAMEA Radiopharmaceutical Market Size by Country
  10. 12.3.1 SAMEA Radiopharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Radiopharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Radiopharmaceutical Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Radiopharmaceutical Value Chain Analysis
  2. 13.1.1 Radiopharmaceutical Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Radiopharmaceutical Production Mode & Process
  6. 13.2 Radiopharmaceutical Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Radiopharmaceutical Distributors
  9. 13.2.3 Radiopharmaceutical Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst